Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2008-07-08
2008-07-08
Eyler, Yvonne (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
Reexamination Certificate
active
10433668
ABSTRACT:
The present invention provides uses of compounds that bind selectively to cells undergoing perturbations and alterations of their normal membrane organization, while binding to a lesser degree to cell having membranes of normal organization. These compounds are termed perturbed-membrane-binding compounds (PMBC). The PMBC group of compounds includes new compounds and also known compounds.
REFERENCES:
patent: 5399501 (1995-03-01), Pope et al.
patent: 451 824 (1991-10-01), None
patent: 1686373 (1991-10-01), None
patent: WO 99/27921 (1999-06-01), None
Atchanassakis et al., Journal of Receptors and Signal Transduction Research, 1999, 19(1-4), 143-154.
Verga et al., Mechanism of Allergic Cross-reactions I Multispecific Binding of Ligands to a Mouse Monoclonal Anti-DNA IgE Antibody, Molecular Immunology, 1991, 28(6), 641-54.
Monogrodsky et al., Inhibition of pokeweed Mitogen-induced B Cell Differentiation by Compounds Containing Primary Amine or Hydrazine Groups, Clinical and Experimental Immunology, 1985, 59(1), 69-76.
Olive et al., Characterization of the uptake and toxicity of a fluorescent thiol reagent (p. 349-353), Cytometry, 3, (5) 1982.
Rice, G, et al., “Use ofN-Σ- dansyl-L-lysine and flow cytometry to identify heat-killed mammalian cells” Int. J. Hyperthermia 1, pp. 185-191 (1985).
Rehse, K, et al., “Oligoamines with Fluorescent Properties, Part B: Fluorophores in the Molecular Periphery”. Arch. Pharm. 327, pp. 399-404 1994.
Muczynski, K, et al., “Incorporation of Dansylated Phospholipids and Dehydroergosterol into Membranes Using a Phospholipid Exchange Protein” Biochemistry 22, pp. 6037-6048 (1983).
Sekiguchi, R, et al., “The use of Dansyl Lysine to assess heat damage and theromotolerance of normal tissues” I.J. Radiation Oncology Biol. Phys. 14, pp. 983-988 (1988).
Epps, D, et al., “Determination of Dissociation Constants of High Affinity (pM) Human Renin Inhibititos: Application to Analogues of Ditekiren” J. Med. Chem. 34, pp. 2107-2112 (1991).
Fratazzi, C, et al., “Programmed Cell Death ofMycobacterium aviumSerovar 4- Infected Human Macrophages Prevents the Mycobacteria from Spreading and Induces Mycobacterial Growth Inhibition by Freshly Added, Uninfected Macrophages” Journal of Immunology 158, pp. 4320-4327 (1997).
Selir,N, et al., “Polyamine sulfonamides with NMDA antagonist properties are potent calmodulin antagonists and cytotoxic agents” The International Journal of Biochemistry & Cell Biology 30 pp. 393-406 (1998).
Rodgers,G, et al., “Formation of Factor Va by Atherosclerotic Rabbit Aorta Mediates Factor Xa -catalyzed Prothrombin Activation” Journal Clinical Invest. 81, pp. 1911-1919 (1988).
Callaghan, R, et al., “A comparison of membrane properties and composition between cell lines selected and tranfected for multi-drug resistance” Br. J. Cancer 66, pp. 781-786 (1992).
Taylor Jr., F.B., et al., “ DEGR-Factor Xa Blocks Disseminated Intravascular Coagulation Initiated byEscherichia coliWithout Preventing Shock or Organ Damage.”Blood 178, pp. 364-368 (1991).
Hirose, K, et al., “Activated Protein C Reduces the Ischemia/Reperfusion-Induced Spinal Cord Injury in Rats by Inhibiting Neutrophil Activation” Annals of Surgery 232, pp. 272-280 (2000).
Humphries, G, et al., “Cholesterol-Free Phospholipid Domains May be The Membrane Feature selected by N-Σ-Dansyl-L-Lysine and Merocyanine 540” Biochemical and Biophysical Research Communications 111, pp. 768-774 (1983).
Robson, C, et al., “Chemical Synthesis and Biological Properties of Novel Fluorescent Antifolates in Pgp and MRP Overexpressing Tumor Cell Lines” Biochemical Pharmacology 56, pp. 807-816 (1998).
Berlot, J.P., et al., “Preparation of a dansylated fibrate, a new fluorescent tool to study peroxisome proliferation. Effect on hepatic-derived cell lines” Biochimie 79, pp. 145-150 (1997).
Hayakawa, M, et al., “ Effects of mono dansyl cadaverine on platelet aggregations, blood coagulations and erythrocyte deformabilities” Japanese Journal of Geriatrics. 22, pp. 144-150 (Mar. 2, 1985) XP01127498.
Stary, H, et al., “A Definition of Advanced Types of atherosclerotic Lesions and a Histological Classification of Atherosclerosis” Circulation 92, pp. 1355-1374 (1995).
Van den Eijnde, S, et al., “Phosphatidylserine plasma membrane asymmetry in vivo: a pancellular phenomenon which alters during apoptosis” Cell Death and Differentiation 4, pp. 311-316, (1997).
Sims, P, et al., “Unraveling the Mysteries of Phospholipid Scrambling” Thromb Haemost 86, pp. 266-275 (2001).
Pugsley, P, et al., “The Impact of Microemboli During Cardiopulmonary Bypass on Neuropsychological Functioning” Stroke 25, pp. 1393-1399 (1994).
Martin, J, et al., “Early Redistribution of Plasma Membrane Phosphatidylserine is a General Feature of Apoptosis Regardless of the Initiating Stimulus: Inhibition by Overexpression of Bcl-2 and Abl” J. Exp. Med. 182, pp. 1545-1556 (1995).
Mallat, Z, et al., “Colocalization of Cpp-32 with Apoptotic Cells in Human Atherosclerotic Plaques” Circulation 96, pp. 424-428 (1997).
Kockx, M, et al., “Apoptosis atherosclerosis: beneficial or detrimental?” Cardiovascular Research 45, pp. 736-746 (2000).
Bursch, W, et al., “Cell death by apoptosis and its protective role against disease” TiPS 13, pp. 245-251 (1992).
Bratton, D, et al., “Appearance of Phosphatidylserine on Apoptotic Cells Requires Calcium-mediated Nonspecific Flip-Flop and Is Enhanced by Loss of the Aminophospholipid Translocase” The Journal of Biological Chemistry 272, pp. 26159-26165 (Oct. 17, 1997).
Bombeli, T, et al., “Apoptotic Vascular Endothelial Cells Become Procoagulant” Blood 89, pp. 2429-2442 (1997).
Bevers, E, et al., “Lipid translocation across the plasma membrane of mammalian cells” Biochimica et Biophysica Acta 1439, pp. 317-330 (1999).
Olive, P.L., et al. “Characterization of the Uptake and Toxicity of a Fluorescent Thiol Reagent”,Cytometry, vol. 3, No. 5, p. 349-353, (1982).
Lazarides, E., et al. “Fluorescent localization of membrane sites in glycerinated chicken skeletal muscle fibers and the relationship of these sites to the protein composition of the Z disc”, Biochemistry, vol. 75, No. 8, p. 3683-3687, (Aug. 1978) .
Hochstrate, P., et al. “On the evaluation of Photoreceptor Properties by Micro-Fluorimetric Measurements of Fluorochrome Diffusion”,Biophysic of Structure and Mechanism, vol. 6, p. 125-138, (1980).
Hammermeister, D.E., et al. “Characterization of dansylated glutathione, glutathione disulfide, cysteine and cystine by narrow bore liquid chromatography/electrospray ionization mass spectrometry”,Rapid Communications in Mass Spectrometry, vol. 14, p. 503-508, (2000).
Ebner Sharon
Shievan Anat
Ziv Ilan
Eyler Yvonne
Hopkins Susanne M.
NST Neurosurvival Technologies Ltd.
Nwaonicha Chukwuma O
The Nath Law Group
LandOfFree
Perturbed membrane-binding compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Perturbed membrane-binding compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Perturbed membrane-binding compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3928203